Работы, цитирующие эту работу

Работ: 9

Работа: Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1. Oxidation of Innate Immune Checkpoint CD47 on Cancer Cells with Non-Thermal Plasma

   Abraham Lin, Jamoliddin Razzokov, Hanne Verswyvel +7

   СтатьяPlasma Applications and DiagnosticsCancers2021Цитирований: 9

   ABIABI:AkademIndex/openalex/2026.other.019981

2. Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases

   Veronika Blum, Beat Müller, Silvia Höfer +7

   СтатьяCancer Immunotherapy and BiomarkersEuropean Journal of Dermatology2018Цитирований: 0

   ABIABI:AkademIndex/openalex/2018.article.000039

3. Translational research of new developments in targeted therapy of colorectal cancer

   Lei Yang, N. E. Atakhanova, Meryelem Tania Churampi Arellano +9

   Обзорная статьяColorectal Cancer Treatments and StudiesPathology - Research and Practice2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.review-article.000055

4. Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy

   Qianqian Huang, Fan Tong, Jiantao Chen +5

   Обзорная статьяNanoplatforms for cancer theranosticsAdvanced Science2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.review-article.000021

5. Regulatory T Cells in Colon Cancer: Implications for Pathogenesis, Prognosis and Emerging Therapeutic Strategies

   Faris Anad Muhammad, Abdulkareem Shareef, S. Renuka Jyothi +10

   Обзорная статьяT-cell and B-cell ImmunologyImmunological Investigations2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.review-article.000109

6. Nanotechnology-based shikonin delivery strategies for modulating the tumor immune microenvironment efficacy

   Dipika Ramdas Kalambhe, Akmal M. Asrorov, Nurkhodja Mukhammedov +3

   Обзорная статьяBioactive Compounds and Antitumor AgentsDrug Delivery and Translational Research2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.review-article.000221

7. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

   Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

   СтатьяCancer Immunotherapy and BiomarkersClinical & Translational Oncology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.002768

8. Pyroptosis-inducing nanomedicines: A dual-mode therapeutic framework for apoptosis-resistant lung cancer

   Qamar Abuhassan, Ghaleb Oriquat, R. Roopashree +5

   СтатьяInflammasome and immune disordersTissue and Cell2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.002974

9. Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignancies

   Qamar Abuhassan, Kamel A. Saleh, S Renuka Jyothi +5

   СтатьяOcular Oncology and TreatmentsBioimpacts2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.024071